bendamustine hydrochloride has been researched along with Neurolymphomatosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Aisa, Y; Ito, C; Kadota, S; Kurosawa, S; Nakayama, H; Nakazato, T; Okubo, S; Sakurai, A; Shinmura, K | 1 |
1 other study(ies) available for bendamustine hydrochloride and Neurolymphomatosis
Article | Year |
---|---|
Polatuzumab vedotin plus bendamustine and rituximab (Pola-BR) was effective for neurolymphomatosis in a patient with refractory diffuse large B-cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Humans; Immunoconjugates; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Neurolymphomatosis; Rituximab | 2023 |